Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
27.01 USD | -6.99% | +5.92% | +165.35% |
Apr. 11 | Oppenheimer Initiates Coverage on Q32 Bio With Outperform Rating, $50 Price Target | MT |
Apr. 03 | Q32 Bio Inc. Appoints Lee Kalowski as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+165.35% | 346M | |
-3.23% | 102B | |
+1.66% | 96.29B | |
+2.13% | 22.18B | |
-15.87% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.71% | 16.36B | |
+5.90% | 13.97B | |
+33.99% | 12.17B |
- Stock Market
- Equities
- QTTB Stock
- News Q32 Bio Inc.
- Piper Sandler Initiates Q32 Bio With Overweight Rating, $45 Price Target